Skip to main content

Advertisement

SpringerLink
Log in

Imaging findings of recurrent pancreatic cancer following resection

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Pancreatic cancer is a challenging malignancy to treat, largely due to aggressive regional involvement, early systemic dissemination, high recurrence rate, and subsequent low patient survival. Generally, 15–20% of newly diagnosed pancreatic cancers are candidates for possible curative resection. Eighty percent of these patients, however, will experience locoregional or distant recurrence in first 2 years. Although there is no strong evidence-based guideline for optimal surveillance after pancreatic cancer resection, careful comparison of surveillance follow-up multi-detector CT (MDCT) studies with a postoperative baseline MDCT examination aids detection of early recurrent pancreatic cancer. In this review article, we describe imaging findings suggestive of recurrent pancreatic cancer and review routine and alternative imaging options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. Cancer J Clin 62:10–29

    Article  Google Scholar 

  2. Barugola G, Partelli S, Marcucci S, et al. (2009) Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol 16:3316–3322

    Article  PubMed  Google Scholar 

  3. Kimura K, Amano R, Nakata B, et al. (2014) Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. World J Surg Oncol 12:360

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cloyd JM, Katz MH, Prakash L, et al. (2017) Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience. J Gastroint Surg 21:164–174

    Article  Google Scholar 

  5. Khorana AA, Mangu PB, Berlin J, et al. (2017) Potentially curable pancreatic cancer: american society of clinical oncology clinical practice guideline update. J Clin Oncol 35:2324–2328

    Article  PubMed  Google Scholar 

  6. Khatcheressian JL, Wolff AC, Smith TJ, et al. (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091–5097

    Article  PubMed  Google Scholar 

  7. Desch CE, Benson AB 3rd, Somerfield MR, et al. (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519

    Article  PubMed  Google Scholar 

  8. O’Reilly EM, Lowery MA (2012) Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers. Cancer Journal (Sudbury, Mass) 18:609–613

  9. NCCN clinical practice gudielines in oncology: pancreatic adenocarcinoma. In 2012; Version 2.

  10. Cascinu S, Falconi M, Valentini V, Jelic S (2010) Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v55–58

    Article  PubMed  Google Scholar 

  11. Tseng JF, Raut CP, Lee JE, et al. (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935–949; discussion 949–950

  12. Katz MH, Fleming JB, Pisters PW, Lee JE, Evans DB (2008) Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248:1098–1102

    Article  PubMed  Google Scholar 

  13. Ishigami K, Yoshimitsu K, Irie H, et al. (2008) Significance of perivascular soft tissue around the common hepatic and proximal superior mesenteric arteries arising after pancreaticoduodenectomy: evaluation with serial MDCT studies. Abdom Imaging 33:654–661

    Article  PubMed  Google Scholar 

  14. Golcher H, Brunner TB, Witzigmann H, et al. (2015) Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial. Strahlentherapie und Onkologie 191:7–16

    Article  PubMed  Google Scholar 

  15. Casadei R, Di Marco M, Ricci C, et al. (2015) Neoadjuvant chemoradiotherapy and surgery versus surgery alone in resectable pancreatic cancer: a single-center prospective, randomized, controlled trial which failed to achieve accrual targets. J Gastroint Surg 19:1802–1812

    Article  Google Scholar 

  16. Evans DB, Varadhachary GR, Crane CH, et al. (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26:3496–3502

    Article  CAS  PubMed  Google Scholar 

  17. Van den Broeck A, Sergeant G, Ectors N, et al. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604

    Article  PubMed  Google Scholar 

  18. Howard TJ, Krug JE, Yu J, et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345; discussion 1345–1336

  19. Ozaki H, Hiraoka T, Mizumoto R, et al. (1999) The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 29:16–22

    Article  CAS  PubMed  Google Scholar 

  20. Pawlik TM, Gleisner AL, Cameron JL, et al. (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618

    Article  PubMed  Google Scholar 

  21. Shimada K, Sakamoto Y, Nara S, Esaki M, Kosuge T, Hiraoka N. (2010) Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma. World J Surg

  22. Winter JM, Cameron JL, Campbell KA, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210; discussion 1210–1191

  23. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046

    Article  PubMed  Google Scholar 

  24. Abrams RA, Grochow LB, Chakravarthy A, et al. (1999) Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 44:1039–1046

    Article  CAS  PubMed  Google Scholar 

  25. Kinsella TJ, Seo Y, Willis J, et al. (2008) The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer. Am J Clin Oncol 31:446–453

    Article  CAS  PubMed  Google Scholar 

  26. Nishio K, Kimura K, Amano R, et al. (2017) Preoperative predictors for early recurrence of resectable pancreatic cancer. World J Surg Oncol 15:16

    Article  PubMed  PubMed Central  Google Scholar 

  27. La Torre M, Nigri G, Lo Conte A, et al. (2014) Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection? Gut Liver 8:102–108

    Article  PubMed  Google Scholar 

  28. Gutt R, Liauw SL, Weichselbaum RR (2009) Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol 6:38–46

    Article  PubMed  Google Scholar 

  29. Varadhachary GR, Wolff RA, Crane CH, et al. (2008) Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26:3487–3495

    Article  CAS  PubMed  Google Scholar 

  30. Tzeng CW, Fleming JB, Lee JE, et al. (2012) Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB 14:365–372

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hishinuma S, Ogata Y, Tomikawa M, et al. (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastroint Surg 10:511–518

    Article  Google Scholar 

  32. Kayahara M, Nagakawa T, Ueno K, et al. (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118–2123

    Article  CAS  PubMed  Google Scholar 

  33. Neoptolemos JP, Stocken DD, Friess H, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

    Article  CAS  PubMed  Google Scholar 

  34. Strobel O, Hartwig W, Hackert T, et al. (2013) Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20:964–972

    Article  PubMed  Google Scholar 

  35. Horvat N, Godfrey EM, Sadler TJ, et al. (2017) Subclinical focal Cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic Ductal Adenocarcinoma and Biliary tree intervention. Cancer Imaging 17:21

    Article  PubMed  PubMed Central  Google Scholar 

  36. Borad MJ, Saadati H, Lakshmipathy A, et al. (2009) Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature. Yale J Biol Med 82:1–6

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Joffe N, Antonioli DA (1978) Osteoblastic bone metastases secondary to adenocarcinoma of the pancreas. Clin Radiol 29:41–46

    Article  CAS  PubMed  Google Scholar 

  38. Groot VP, Rezaee N, Wu W, et al. (2017) Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg

  39. Kitajima K, Murakami K, Yamasaki E, et al. (2010) Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Mol Imaging Biol 12:452–459

    Article  PubMed  Google Scholar 

  40. Ruf J, Lopez Hanninen E, Oettle H, et al. (2005) Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology 5:266–272

  41. Sperti C, Pasquali C, Bissoli S, et al. (2010) Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastroint Surg 14:131–140

    Article  Google Scholar 

  42. Izuishi K, Yamamoto Y, Sano T, et al. (2010) Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer. J Gastrointest Surg 14:1151–1158

    Article  PubMed  Google Scholar 

  43. Kitajima K, Murakami K, Yamasaki E, et al. (2009) Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Mol Imaging Biol

  44. Cameron K, Golan S, Simpson W, et al. (2011) Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging 36:463–471

    Article  PubMed  Google Scholar 

  45. Higashi T, Saga T, Nakamoto Y, et al. (2003) Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) –usefulness and limitations in “clinical reality”. Ann Nuclear Med 17:261–279

    Article  Google Scholar 

  46. Belyaev O, Munding J, Tannapfel A, Uhl W (2015) False-positive PET/CT after cyanoacrylate sealing of a pancreaticojejunostomy. J Gastrointest Surg 19:984–985

    Article  PubMed  Google Scholar 

  47. Diederichs CG, Staib L, Vogel J, et al. (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109–116

    Article  CAS  PubMed  Google Scholar 

  48. Jung W, Jang JY, Kang MJ, et al. (2016) The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients. HPB 18:57–64

    Article  PubMed  Google Scholar 

  49. Fritz F, Skornitzke S, Hackert T, et al. (2016) Dual-energy perfusion-CT in recurrent pancreatic cancer—preliminary results. RoFo 188:559–565

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Special thanks to Kelly Kage, medical illustrator.

Author information

Authors and Affiliations

  1. Section of Abdominal Imaging, Department of Diagnostic Radiology, MD Anderson Cancer Center, University of Texas, 1400 Pressler St. Unit 1437, Houston, TX, 77030, USA

    S. Javadi, P. Bhosale, S. de Castro Faria, O. Le & E. P. Tamm

  2. Department of Interventional Radiology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA

    N. Karbasian

  3. Department of Surgical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA

    M. H. Katz

  4. Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA

    E. J. Koay

Authors
  1. S. Javadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Karbasian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Bhosale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. de Castro Faria
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Le
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. H. Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. J. Koay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. P. Tamm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Javadi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this review article, formal consent was not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Javadi, S., Karbasian, N., Bhosale, P. et al. Imaging findings of recurrent pancreatic cancer following resection. Abdom Radiol 43, 489–496 (2018). https://doi.org/10.1007/s00261-017-1397-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1397-8

Keywords

Search

Navigation